SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wu CW, Terkeltaub R, Kalunian KC. Calcium-containing crystals and osteoarthritis: implications for the clinician. Curr Rheumatol Rep 2005; 7: 2139.
  • 2
    Swan A, Heywood B, Chapman B, Seward H, Dieppe P. Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout. Ann Rheum Dis 1995; 54: 82530.
  • 3
    Silman AJ. Calcium pyrophosphate dihydrate (CPPD) deposition disease. In: HochbergM, editor. Epidemiology of the rheumatic disease. 2nd ed. Oxford: Oxford University Press; 2001. p. 24758.
  • 4
    Sanmarti R, Kanterewicz E, Pladevall M, Panella D, Tarradellas JB, Gomez JM. Analysis of the association between chondrocalcinosis and osteoarthritis: a community based study. Ann Rheum Dis 1996; 55: 303.
  • 5
    Felson DT, Anderson JJ, Naimark A, Kannel W, Meenan RF. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol 1989; 16: 12415.
  • 6
    Zhang Y, Xu L, Nevitt MC, Aliabadi P, Yu W, Qin M, et al. Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum 2001; 44: 206571.
  • 7
    Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RD. The prevalence of knee osteoarthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1987; 30: 9148.
  • 8
    Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Am J Epidemiol 2002; 156: 10217.
  • 9
    Environmental Protection Agency (US). Methods for the determination of metal in environmental samples. Supplement 1-EPA/600/R-94-111; May 1994.
  • 10
    Environmental Protection Agency (US). Methods for chemical analysis of water and wastes. EPA-600/4-79-020, Cincinnati: EPA, EMSL; 1983.
  • 11
    Zhang Y, Xu L, Nevitt MC, Niu J, Goggins JP, Aliabadi P, et al. Lower prevalence of hand osteoarthritis among Chinese subjects in Beijing compared with white subjects in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum 2003; 48: 103440.
  • 12
    Doherty M, Watt I, Dieppe PA. Localised chondrocalcinosis in post-meniscectomy knees. Lancet 1982; 1: 120710.
  • 13
    Glass JS, Grahame R. Chondrocalcinosis after parathyroidectomy. Ann Rheum Dis 1976; 35: 5215.
  • 14
    Rynes RI, Merzig EG. Calcium pyrophosphate crystal deposition disease and hyperparathyroidism: a controlled, prospective study. J Rheumatol 1978; 5: 4608.
  • 15
    Wright GD, Doherty M. Calcium pyrophosphate crystal deposition is not always ‘wear and tear’ or aging. Ann Rheum Dis 1997; 56: 5868.
  • 16
    Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 2005; 42: 3570.
  • 17
    Mihai R, Farndon JR. Parathyroid disease and calcium metabolism. Br J Anaesth 2000; 85: 2943.
  • 18
    Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: a tale of two cities—New York and Beijing. Int J Fertil Womens Med 2000; 45: 15865.
  • 19
    Genant HK. Roentgenographic aspects of calcium pyrophosphate dihydrate crystal deposition disease (pseudogout). Arthritis Rheum 1976; 19: 30728.
  • 20
    Rosenthal AK, Ryan LM. Calcium pyrophoshate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: MorelandLW, editor. Arthritis and allied conditions. 15th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 237396.
  • 21
    Halverson PB. Basic calcium phosphate (apatite, octacalcium phosphate, tricalcium phosphate) crystal deposition disease and calcinosis. In: MorelandLW, editor. Arthritis and allied conditions. 15th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 2397416.